CAJ | 학술논문

目的：观察食管癌患者三维适形放疗联合回生口服液对进食的影响。方法接受三维适形放疗的食管癌患者23例随机分为试验组和对照组，试验组12例患者给予放疗和回生口服液，而对照组11例患者仅给予放疗，放疗过程中评价毒副反应，治疗开始至2月评价进食情况，所有患者放疗前后检查体重及食管X线片病变长度改变。结果试验组治疗后进食评分提高8例(66.7%)，减少2例(16.7%)，体重评分提高3例(25%)，降低3例(25%)，与对照组比较均有显著性(p<0.05)；PS评分试验组治疗后评分降低8例(66.7%)，升高2例(16.7%)，对照组降低4例(36.4%)，升高3例(27.3%)，两组差异有显著性(p<0.05)。毒副反应试验组较对照组轻。结论放疗联合回生口服液可改善食管癌患者进食，提高总体生活质量，且一定程度减轻放疗毒副反应。
목적：관찰식관암환자삼유괄형방료연합회생구복액대진식적영향。방법접수삼유괄형방료적식관암환자23례수궤분위시험조화대조조，시험조12례환자급여방료화회생구복액，이대조조11례환자부급여방료，방료과정중평개독부반응，치료개시지2월평개진식정황，소유환자방료전후검사체중급식관X선편병변장도개변。결과시험조치료후진식평분제고8례(66.7%)，감소2례(16.7%)，체중평분제고3례(25%)，강저3례(25%)，여대조조비교균유현저성(p<0.05)；PS평분시험조치료후평분강저8례(66.7%)，승고2례(16.7%)，대조조강저4례(36.4%)，승고3례(27.3%)，량조차이유현저성(p<0.05)。독부반응시험조교대조조경。결론방료연합회생구복액가개선식관암환자진식，제고총체생활질량，차일정정도감경방료독부반응。
Objective:Observation of eating affect on treating esophageal cancer with retrogradation of oral liquid plus 3D conformal radiother-apy. Method:23 patients of esophageal cancer with 3D conformal radiotherapy were randomly divided into experimental group and control group. Ex-perimental group of 12 cases would be treated with radiation plus retrogradation of oral liquid. And the control group of 11 patients were only given ra-diotherapy. Treatment began to two months, radiotherapy toxicity and eating affect would be evaluated. Before and after radiotherapy, all cases would be checked weight and esophageal X-ray lesion length change. Results:After treatment in experimental group of 12 cases, 8 cases improved with eating affect scores (66. 7%), 2 cases reduced (16. 7%). And 3 patients increased in weight scores (25%), same cases lower (25%), which compared with the control group were significant (p < 0. 05). After treatment 8 cases lower with PS score group score (66. 7%), however 4 cases were decreased in control group (36. 4%), the rise in 3 cases (27. 3%), which were significant difference in the two groups (p < 0. 05). About adverse reaction, the experimental group was lighter than that of the control group. Conclusions:Radiotherapy combined retrogradation of oral liquid could improve feeding in patients with esophageal cancer, and improve the overall quality of life, and reduce radiation toxicity partly.